The oral delivery of small-molecule drugs with poor aqueous solubility represents an ongoing drug development challenge. Amorphous solid dispersions (ASDs) and lipid-based formulations (LBFs) have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results